Advancis Pharmaceutical Corporation (AVNC) Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
6/28/2007 11:42:50 AM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
6/27/2007 9:58:57 AM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Announces FDA Acceptance of Amoxicillin PULSYS NDA
5/22/2007 10:52:32 AM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Reports First Quarter 2007 Results
5/8/2007 11:40:04 AM
More...
|
Advancis Pharmaceutical Corporation (AVNC) to Announce First Quarter 2007 Financial Results on May 8, 2007
5/3/2007 12:03:28 PM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Appoints New Board Member
4/24/2007 10:58:00 AM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Closes Private Placement of Common Equity Raising $24 Million
4/19/2007 10:49:42 AM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Reports Full Year 2006 Results and 2007 Corporate Initiatives
3/28/2007 12:24:52 PM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
3/23/2007 11:56:39 AM
More...
|
Advancis Pharmaceutical Corporation (AVNC) Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
2/28/2007 11:15:32 AM
More...
|
|